Benzinga | Nov 11, 2020 10:17AM EST

Earnings Preview for Bionano Genomics

On Thursday, November 12, Bionano Genomics (NASDAQ: BNGO) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Analysts are predicting Bionano Genomics will report a loss of $0.05 per share on revenue of $2.07 million. In the same quarter last year, Bionano Genomics reported a loss per share of $0.59 on revenue of $3.31 million.

Why Analyst Estimates And Earnings Surprises Are Important

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

The analyst consensus estimate would represent a 91.53% increase in the company's EPS figure. Sales would be down 37.52% from the same quarter last year. Bionano Genomics's reported EPS has stacked up against analyst estimates in the past like this:

Quarter Q2 2020 Q1 2020 Q4 2020 Q3 2019EPS Estimate -0.09 -0.21 -0.18 -0.45EPS Actual -0.09 -0.30 -0.23 -0.59Revenue Estimate 860.00 K 1.70 M 4.42 M 4.44 MRevenue Actual 1.18 M 1.14 M 2.79 M 3.31 M

Stock Performance

Over the past 52-week period, shares of Bionano Genomics have declined 49.81%.

Do not be surprised to see the stock move on comments made during its conference call. Bionano Genomics is scheduled to hold the call at 16:30:00 ET and can be accessed here.